Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Egypt flag Egypt · Delayed Price · Currency is EGP
4.550
-0.060 (-1.30%)
At close: Apr 28, 2026
38.13%
Market Cap 9.22B
Revenue (ttm) 4.10B
Net Income (ttm) 268.61M
Shares Out 2.00B
EPS (ttm) 0.13
PE Ratio 34.51
Forward PE 16.66
Dividend 0.04 (0.87%)
Ex-Dividend Date n/a
Volume 14,709,460
Average Volume 14,608,436
Open 4.610
Previous Close 4.610
Day's Range 4.500 - 4.660
52-Week Range 3.022 - 5.120
Beta 0.36
RSI 62.31
Earnings Date May 14, 2026

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. The company manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; imports pharmaceutical reagents and raw materials; and produces food supplements for human use. It offers a portfolio of ... [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol RMDA
Full Company Profile

Financial Performance

In 2025, EGX:RMDA's revenue was 4.10 billion, an increase of 47.94% compared to the previous year's 2.77 billion. Earnings were 268.61 million, a decrease of -26.17%.

Financial Statements

News

There is no news available yet.